Prognostic Significance of the Mismatch Repair Gene in Colorectal Cancer Patients Treated with 5-Fluorouracil Chemotherapy.
| Autor: | Kanet Kanjanapradit, Samornmart Kanngurn, Theranutch Boonpipattanapong, Surasak Sangkhathat |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2011 |
| Předmět: | |
| Zdroj: | Journal of Health Science and Medical Research (JHSMR), Vol 29, Iss 1, Pp 27-37 (2011) |
| Druh dokumentu: | article |
| ISSN: | 2586-9981 2630-0559 |
| Popis: | Objective: To correlate mismatch repair gene defects with the outcomes of colorectal carcinoma patients having undergone adjuvant chemotherapy containing 5-fluorouracil. Material and Methods: The records of all stage II, III and IV colorectal carcinoma cases treated at Songklanagarind Hospital from 1994-2003 were examined for the study. There were 140 patients and all had received adjuvant 5-fluorouracil-based chemotherapy. The mismatch repair gene proteins mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1) and mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) (MSH2) in tumor cells were evaluated by immunohistochemistry. Negative staining confirmed abnormalities in or complete loss of mismatch repair genes. Survival analysis was carried out using the Kaplan-Meier method and the Cox Proportional Hazards regression. Results: Mismatch repair gene defects were detected in 36 cases (25.7%): only MLH1 defects in 15 cases (10.7%), only MSH2 defects in 10 cases (7.1%), and both MLH1 and MSH2 defects in 11 cases (7.8%). Survival analysis showed no significant differences between mutated mismatch repair gene patients and normal mismatch repair gene patients (95% CI=0.35 to 0.67, p=0.54). Conclusion: Mismatch repair gene defects do not predict the prognosis of colorectal cancer patients treated with 5-fluorouracil-based chemotherapy. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|